Natural progression of menstrual pain in nulliparous women at reproductive age: An observational study

Journal of the Chinese Medical Association

Volumn 69, Issue 10, 2006, Pages 484-488

  Juang, Chi Mou ^a,b   Yen, Ming Shien ^a   Horng, Huann Cheng ^a   Cheng, Chih Yao ^a   Yuan, Chiou Chung ^a   Chang, Chia Ming ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Multidimensional scoring; Nulliparous; Primary dysmenorrhea

Indexed keywords

ANALGESIC AGENT; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLIMACTERIUM; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DYSMENORRHEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NULLIPARA; OBSERVATIONAL STUDY; ORAL CONTRACEPTION; PAIN ASSESSMENT; PELVIS PAIN SYNDROME; QUESTIONNAIRE; RISK FACTOR; SCORING SYSTEM; SEXUAL INTERCOURSE; SYSTEMIC DISEASE;

EID: 33750865349     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70313-2     Document Type: Article

References (19)

1. Klein JR, Litt IF. Epidemiology of adolescent dysmenorrhea. Pediatrics 1981;68:661-4.
2. Dmitrovic R, Peter B, Cvitkovic-Kuzmic A, Strelec M, Kereshi T. Severity of symptoms in primary dysmenorrhea - a Doppler study. Eur J Obstet Gynecol Reprod Biol 2003;107:191-4.
3. Milsom I, Sundell G, Andersch B. The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea. Contraception 1990;42:497-506.
4. Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol 1996;87:55-8.
5. Lundstrom V, Green K. Endogenous levels of prostaglandin F2alpha and its main metabolites in plasma and endometriurn of normal and dysmenorrheic women. Am J Obstet Gynecol 1978; 30:640-6.
6. Chan WY, Dawood MY, Fuchs F. Relief of dysmenorrhea with the prostaglandin synthetase inhibitor ibuprofen: effect on prostaglandin levels in menstrual fluid. Am J Obstet Gynecol 1979; 35:102-8.
7. Nigam S, Benedetto C, Zonca M, Leo-Rossberg I, Lubbert H, Hammerstein J. Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea. Eicosanoids 1991;4:137-41.
8. Bieglmayer C, Hofer G, Kainz C, Reinthaller A, Kopp B, Janisch H. Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives. Gynecol Endocrinol 1995; 9:307-12.
9. Weissman AM, Hartz AJ, Hansen MD, Johnson SR. The natural history of primary dysmenorrhoea: a longitudinal study. Br J Obstet Gynaecol 2004;111:345-52.
10. Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol 1990;97:588-94.
11. Harlow SD, Park M. A longitudinal study of risk factors for the occurrence, duration and severity of menstrual cramps in a cohort of college women. Br J Obstet Gynaecol 1996;103: 1134-42.
12. Biberoglu KO, Behrman SJ. Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness. Am J Obstet Gynecol 1981;139:645-54.
13. Vercellini P, Aimi G, Busacca M, Apolone G, Uglietti A, Crosignani PG. Laparoscopic uterosacral ligament resection for dysmenorrhea associated with endometriosis: results of a randomized, controlled trial. Fertil Steril 2003;80:310-9.
14. Messing K, Saurel-Cubizolles MJ, Bourgine M, Kaminski M. Factors associated with dysmenorrhea among workers in French poultry slaughterhouses and canneries. J Occup Med 1993;35: 493-500.
15. Pullon S, Reinken J, Sparrow M. Prevalence of dysmenorrhea in Wellington women. N Z Med J 1988;101:52-4.
16. Callejo J, Diaz J, Ruiz A, Garcia RM. Effect of a low-dose oral contraceptive containing 20 microg ethinylestradiol and 150 microg desogestrel on dysmenorrhea. Contraception 2003;68: 183-8.
17. Vercellini P, Frontino G, De Giorgi O, Pietropaolo G, Pasin R, Crosignani PG. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 2003;80: 560-3.
18. Hendrix SL, Alexander NJ. Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive. Contraception 2002;66:393-9.
19. Harel Z. A contemporary approach to dysmenorrhea in adolescents. Pediatr Drugs 2002;4:797-805.